January 2025 FDA Recall Fentanyl System by Alvogen, Inc
D-0245-2025 - Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.

This Class I drug recall was voluntarily initiated by Alvogen, Inc on January 31, 2025 for the product Fentanyl System. The FDA reported the reason for recall as defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.. The product was distributed Nationwide and the recall is currently ongoing.

Recall Number: D-0245-2025

Reason for Recall
Defective delivery system - patches could be multi-stacked, adhered one on top of the other, in a single product pouch.
Initiated
01-31-2025
Reported
02-26-2025
Quantity
112,128 cartons (5 pouches/carton)

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Fentanyl Transdermal System CII, 25mcg/h, packaged in a pouch, further packaged in 5-count carton, Rx only, Distributed by: Alvogen, Inc., Pine Brook, NJ 07058, Manufactured by: Kindeva Drug Delivery L/P, Northridge, CA 91324, NDC 47781-424-47.

Batch or Lot Expiration Information

Lot# : 108319, Exp: 04/30/2027